Guilhem Bonazzi

Guilhem Bonazzi

Auto-generated profile, based on publicly available information

Guilhem Bonazzi

Pôle Hospitalo-Universitaire ADIS - Autisme neuroDéveloppement et Inclusion Sociale, Le Vinatier, Lyon, France

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2025 in Autism in Adulthood
Verified
Journal Article
Open access
GBGuilhem Bonazzi
Guilhem Bonazzi
EPElodie Peyroux
Elodie Peyroux
LJLucie Jurek
Lucie Jurek
LSLudovic Souiller
Ludovic Souiller
AZAdele Zufferey
Adele Zufferey
CDCaroline Demily
Caroline Demily
Background: The intersection of Autism and Gender Diversity (GD) is an emerging field of research. While prior studies have primarily focused on autistic traits within gender-diverse populations, limited evidence exists on the prevalence and characteristics of GD among individuals with a confirmed Autism Spectrum Disorder (ASD) diagnosis. This study aims to fill this gap through a systematic review and meta-analysis, offering comprehensive insights into the prevalence of GD in autistic individuals and the factors influencing this intersection. Methods: We conducted a systematic review and meta-analysis following the Preferred Reporting Items for Systematic Reviews and Meta-analyses 2020 guidelines. We searched for studies published between 2013 and 2023 in four databases. Inclusion criteria focused on studies assessing GD in children and adult participants with a formal ASD diagnosis based on Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition, criteria. We used random-effects models to estimate prevalence rates, and subgroup analyses explored potential influencing factors, including age, gender assigned at birth, type of GD assessment, ASD diagnosis methodology, and primary objective of the study. Results: From 7133 identified reports, we deemed 24 studies suitable for the systematic review, with 14 meeting all eligibility criteria for meta-analysis, representing 3894 autistic participants. We estimated the pooled prevalence of GD at 7.37% (95% confidence interval [CI]: 4.45–11.98). Subgroup analyses revealed no significant impact of age, type of GD assessment, or diagnostic methodology of ASD on GD prevalence. Although we found a higher prevalence of GD among individuals assigned female at birth (14.54%) compared with those assigned male at birth (8.15%), the difference was not statistically significant. However, studies explicitly addressing GD reported statistically higher GD rates (13.71%) compared with those with other primary objectives (4.71%). Non-binary identities appeared particularly prevalent, but we did not underexplore it due to variability in GD definitions across studies. Conclusion: This study highlights a notable prevalence of GD among autistic individuals, emphasizing the need for inclusive definitions and diagnostic process. Understanding this intersection is crucial for enhancing support services and ensuring equitable access to gender-affirming care for neurodiverse populations.

1 February 2025 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
SCSophie-Athéna Chapron
Sophie-Athéna Chapron
GBGuilhem Bonazzi
Guilhem Bonazzi
LLLaura Di Lodovico
Laura Di Lodovico
JTJulia de Ternay
Julia de Ternay
CLCamille Landmann
Camille Landmann
MAMarc Auriacombe
Marc Auriacombe
Background: In the context of the need to increase treatment options for substance use disorders, recent research has evaluated the therapeutic potential of psychedelics. However, there is an incomplete understanding of psychedelics’ effects on craving, a core symptom of addictive disorders and a predictor of substance use and relapse. Aims: To determine if the use of psychedelics is associated with changes in craving in humans. Methods: A systematic review of the literature, using PubMed, PsycInfo, and Scopus databases up to May 2023. We included all studies assessing any substance craving levels after psychedelic use (protocol registration number CRD42021242856). Results: Thirty-eight published articles were included, corresponding to 31 studies and 2639 participants, pertaining either to alcohol, opioid, cocaine, or tobacco use disorders. Twelve of the 31 included studies reported a significant decrease in craving scores following psychedelic use. All but two studies had methodological issues, leading to moderate to high risk of bias scores. Conclusions: Some psychedelics may show promising anti-craving effects, yet the diversity and high risk of bias of extant studies indicate that these results are to be considered with caution. Further well-controlled and larger-scale trials should be encouraged.

12 October 2026 in LGBT Health
Verified
Journal Article
Closed access
CGClara Gloanec
Clara Gloanec
GBGuilhem Bonazzi
Guilhem Bonazzi
MBMohamed-ElMehdi Boughanmi
Mohamed-ElMehdi Boughanmi
CDCaroline Demily
Caroline Demily
EPElodie Peyroux
Elodie Peyroux
Purpose: This review aimed to determine how autism spectrum disorder (ASD) and autistic traits are assessed in gender-diverse populations. Methods: Following the Preferred Reporting Items for Systematic reviews and Meta-Analyses 2020 guidelines, we conducted a systematic review and meta-analysis of studies published from January 2013 in English or French that focused on gender-diverse individuals and reported diagnostic procedures and/or tools used to assess ASD. Only studies involving human participants were included. Reviews, meta-analyses, case reports, editorials, posters, and conference abstracts were excluded. Two independent reviewers screened records and extracted data using a standardized form, including study design, sample characteristics, diagnostic instruments, and assessment procedures. Data were synthesized qualitatively, and pooled prevalence estimates were calculated using random-effects meta-analysis when appropriate. Methodological quality and risk of bias were assessed using the Joanna Briggs Institute tools for analytical cross-sectional studies and for case-control studies. Results: Twenty-eight studies met the inclusion criteria. Eighteen assessed ASD diagnoses; only six (33%) used robust diagnostic criteria, identifying 100 participants with a confirmed ASD diagnosis (5.4%) among 1855 participants. Other studies relied mainly on self-report or screening instruments. Twenty-three studies examined the broader autism phenotype using 13 different tools. The pooled prevalence of robust ASD diagnosis was 12% (95% confidence interval [CI] = 7%–19%), and broader autism phenotype prevalence was 24% (95% CI = 17%–33%). Conclusions: Few studies met clinical gold standards. Elevated prevalence estimates may reflect methodological variability and barriers to appropriate evaluation. Training in both ASD and gender diversity is essential for inclusive and accurate diagnostic practices.